Further analysis of target prediction and associated pathways showed potential functional explanations of how the rs2829145 variant in lnc-JAM2-6:4, as well as the selected miRNAs, could be involved in the pathogenesis of NAFLD. The gene discussed is JAM2; the disease is metabolic dysfunction-associated steatotic liver disease.